Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Psychiatry Res. 2020 Dec 2;295:113595. doi: 10.1016/j.psychres.2020.113595

Figure 1.

Figure 1.

Change in PHQ-2 and GAD-2 Scores During the Early Months of the COVID-19 Pandemic. N=28 and N=30 participants completed the PHQ-2 and GAD-2, respectively, in both March and April. Comparison of PHQ-2 and GAD-2 raw scores (PHQ-2 95% CI: 0.057–1.05, t=7.01, df=27, p<0.0001; GAD-2 95% CI: 0.40–0.85, df=29, t=5.79, p<0.0001) and positive test thresholds between March and April (PHQ-2 McNemar with continuity correction, χ2=8.5, p=0.004; GAD-2 χ2=3.78, p=0.05).